microdosing semaglutide for weight loss People are 'microdosing' weight-loss drugs. A GP explains what to watch out GLP-1 Microdosing Explained - Gift

These can include personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, history of pancreatitis, certain kidney or gallbladder conditions, pregnancy or breastfeeding, and other individual health factors

There were no injection site reactions in the semaglutide group, and injection site reactions in 11% of liraglutide patients and 6% of placebo patients

In the first case we ever published, a case report treating the first patient who had, initially, early-stage lymphedema, breast cancer-related lymphedema

Abdominal pain occurs because semaglutide slows gastric emptying, causing fullness, bloating, and discomfort, particularly during initial weeks or after dose increases

Berberine also has meaningful effects on lipids (LDL and triglyceride reduction) and some evidence for gut microbiome modulation

Jacobsen, S.H